The U.S. FDA approves Merck's once-a-day hepatitis C drug, Zepatier, which has been found effective among patients in a clinical trial.
BioLineRX announced a collaboration with Merck to test drug combination of BL-8040 and Keytruda to treat pancreatic cancer.
A study conducted by U.S. drug firm Merck found that administering Keytruda to patients with advanced stages of lung cancer significantly improved their chances of survival.
Merck's bezlotoxumab drug reduced Clostridium difficile in patients by 15% following a 12 week treatment.
Ebola vaccine proves to be fully effective in fighting the virus.
